ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ARDS Aridis Pharmaceuticals Inc

0.289
0.00 (0.0%)
Dec 07 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.218
Ask Price 0.3007
News -
Day High

Low
0.15

52 Week Range

High
1.7458

Day Low
Company Name Stock Ticker Symbol Market Type
Aridis Pharmaceuticals Inc ARDS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.289 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.289 0.289
Trades Volume Avg Volume 52 Week Range
0 0 - 0.15 - 1.7458
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.289 USD

Aridis Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.12M 44.57M - 3.09M -30.37M -0.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aridis Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARDS Message Board. Create One! See More Posts on ARDS Message Board See More Message Board Posts

Historical ARDS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.2760.40890.2040.30386413,228,9870.0134.71%
1 Year0.99491.74580.150.46158722,619,507-0.7059-70.95%
3 Years7.008.470.151.10887,722-6.71-95.87%
5 Years8.8012.400.151.15505,284-8.51-96.72%

Aridis Pharmaceuticals Description

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com